Zusammenfassung
Die Ursachen eines nichtarteriitischen retinalen Arterienverschlusses liegen meistens nicht im Auge selbst, sondern sind Folge thrombembolischer Ereignisse, die häufig auf dem Boden arteriosklerotischer Gefäßveränderungen entstehen, die wiederum Folge internistischer Erkrankungen sein können. Im vorliegenden Artikel werden die wichtigsten internistischen Untersuchungen aufgeführt, um entsprechende Risikoerkrankungen zu entdecken, damit eine entsprechende Therapie mit dem Ziel der Reduktion weiterer vaskulärer Ereignisse eingeleitet werden kann. Insbesondere findet auch eine kritische Bewertung bezüglich der Durchführung einer Thrombophiliediagnostik statt.
Abstract
The causes of non-arteritic retinal artery occlusions rarely originate from the eye itself but are mostly the result of thrombo-embolic events which often develop due to atherosclerotic vascular changes, which in turn are often a consequence of internal diseases. In this article the most important internal medical examinations to identify related risk conditions are highlighted, which ensure that appropriate therapy can be initiated to reduce further possible vascular events. Additionally, a critical assessment is made concerning the implementation of thrombophilia diagnostics.
Literatur
Adams RJ, Albers G, Alberts MJ et al (2008) Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 39(5):1647–1652
Bick RL, Alfar H, Goedecke C (2002) Thrombophilic causes of retinal vascular thrombosis: Etiology and treatment outcomes. Clin Appl Thromb Hemost 8(4):315–318
Cahill MT, Stinnett SS, Fekrat S (2003) Meta-analysis of plasma homocysteine, serum folate, serum vitamin B12, and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 136:1136–1150
Cervera R, Piette JC, Font J et al (2000) Antiphospholipid syndrome – Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46:1019–1027
Cobo-Soriano R, Sanchez-Ramon S, Aparicio MJ et al (1999) Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol 128:725–732
Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poo anticoagulant response to activated protein C: preduction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 90:1004–1008
De Moerloose P, Boehlen F (2007) Inherited thrombophilia in arterial disease: A selective review. Semin Hematol 44:106–113
Deutsche Hochdruckliga e.V., DHL® – Deutsche Hypertonie Gesellschaft (2008) Leitlinien zur Behandlung der arteriellen Hypertonie. http://www.hochdruckliga.de
Girolami A, Randi ML, Gavasso S et al (2004) The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: A study of prevalence in 21 patients and review of the literature. J Thromb Thrombolysis 17:139–143
Glueck CJ, Wang P (2009) Ocular vascular thrombotic events: A diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis. Clin Appl Thromb Hemost 15(1):12–18
Glueck CJ, Wang P, Hutchins R et al (2008) Ocular vascular thrombotic events: Central retinal vein and central retinal artery occlusions. Clin Appl Thromb Hemost 14(3):286–294
Greiner K, Peetz D, Winkgen A et al (2001) Genetic thrombophilia in patients with retinal vacular occlusion. Int Ophthalmol 23:155–160
Greven CM, Slusher MM, Weaver RG (1995) Retinal arterial occlusions in young adults. Am J Ophthalmol 120:776
Hayreh SS, Podhajsky PA, Zimmerman MB (2009) Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology 16(10):1928–1936
Hayreh SS, Zimmerman MB (2005) Central retinal artery occlusion: visual outcome. Am J Ophthalmol 140(3):376–391
Kerner W, Brückel J (2008) Definition, Klassifikation und Diagnostik des Diabetes mellitus. Diabetologie 3 (Suppl 2):S131–S133
Kirwan C, Sugrue D, O‚Keefe M (2008) Central retinal artery occlusion due to paroxysmal atrial fibrillation: The importance of Holter monitoring. Ir J Med Sci 177:277–278
Kramer M, Goldenberg-Cohen N, Shapira Y et al (2001) Role of transesophageal echocardiography in the evaluation of patients with retinal artery occlusion. Ophthalmology 108:1461
Larsson J (2000) Central retinal artery occlusion in a patient homozygous for factor V Leiden. Am J Ophthalmol 129:816–817
Lindhoff-Last E, Luxembourg B (2008) Evidence-based indications for thrombophilia screening. VASA 37:19–30
Mannucci PM, Merlini PA, Ardissino D et al (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107:1117–1122
Martinelli I, Battaglioli T, Burgo I et al (2006) Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke. Haematologica 91:844–847
Miserocchi E, Baltatzis S, Foster CS (2001) Ocular features associated with anticardiolipin antibodies: A descriptive study. Am J Ophthalmol 131:451
Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306
Nagy V, Takacs L, Steiber Z et al (2008) Thrombophilic screening in retinal artery occlusion patients. Clin Experiment Ophthalmol 2(3):557–561
Progress Collaborative Group (2000) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358:1033–1041
Recchia FM, Brown GC (2000) Systemic disorders associated with retinal vascular occlusion. Curr Opin Ophthalmol 11:462–467
Ridker PM, Hennekens CH, Lindpaintner K et al (1995) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332:912–917
Rosendaal FR, Siscovick DS, Schwartz SM et al (1997) Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 89:2817–2821
Rudkin AK, Lee AW, Chen CS (2010) Vascular risk factors for central retinal artery occlusion. Eye 24:678–681
Rumelt S, Dorenboim Y, Rehany U (1999) Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 128:733
Schmid D, Hetzel A, Geibel-Zehender A, Schulte-Mönting J (2007) Systemic disease in non-inflammatory branch and central retinal artery occlusion-an overview of 416 patients. Eur J Med res 12(12):593–603
Sharma S, Brown GC, Cruess AF (1998) Accuracy of visible retinal emboli for the detection of cardioembolic lesions requiring anticoagulation or cardiac surgery. Retinal Emboli of Cardiac Origin Study Group. Br J Ophthalmol 82:655
Sharma S, Naqvi A, Sharma SM et al (1996) For the Retinal Emboli of Cardiac Origin Study Group: Transthoracic echocardiographic findings in patients acute retinal arterial obstruction: A retrospetive review. Arch Ophthalmol 114:1189–1192
Stojakovic T, Scharnagl H, März W et al (2007) Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusion. Clin Chim Acta 382(1–2):77–81
Toole JF, Malinow MR, Chambless LE et al (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death – The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291:565–575
Weger M, Renner W, Pinter O et al (2003) Role of factor V Leiden and prothrombin 20210A in patients with retinal artery occlusion. Eye 17:731–734
Willeke A, Gerdsen F, Bauersachs RM, Lindhoff-Last E (2002) Rationelle Thrombophiliediagnostik. Dtsch Ärztebl 99:2111–2118
Wong TY, Kleon R (2002) Retinal arteriolar emboli: Epidemiology and stroke risk. Curr Opin Ophthalmol 13:142–146
Yuzurihara D, Iijima H (2004) Visual outcome in central retinal and branch retinal artery occlusion. Jpn J Ophthalmol 48:490–492
Zotz RB (2008) Die Bedeutung thrombophiler Risikofaktoren bei Patienten mit arteriellen Thrombosen. Hamostaseologie 28:120–129
Dietel M, Suttorp N, Zeitz M (Hrsg) (2009) Harrisons Innere Medizin, 17. Aufl. ABW Wissenschaftsverlag, Berlin
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heinz, J. Internistische Untersuchungen beim nichtarteriitischen retinalen Arterienverschluss. Ophthalmologe 107, 806–813 (2010). https://doi.org/10.1007/s00347-009-2112-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-009-2112-0